Equities Analysts Offer Predictions for InnovAge Q3 Earnings

InnovAge Holding Corp. (NASDAQ:INNV) – Analysts at William Blair raised their Q3 2025 earnings estimates for shares of InnovAge in a research report issued to clients and investors on Tuesday, February 4th. William Blair analyst J. Haase now forecasts that the company will post earnings of ($0.01) per share for the quarter, up from their previous estimate of ($0.02). The consensus estimate for InnovAge’s current full-year earnings is ($0.06) per share. William Blair also issued estimates for InnovAge’s FY2025 earnings at ($0.15) EPS and FY2026 earnings at $0.08 EPS.

A number of other research analysts also recently issued reports on the stock. JPMorgan Chase & Co. restated an “underweight” rating and set a $5.00 target price on shares of InnovAge in a research report on Tuesday, December 17th. KeyCorp began coverage on InnovAge in a research note on Friday, October 11th. They issued a “sector weight” rating for the company.

InnovAge Price Performance

InnovAge stock opened at $3.22 on Friday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.21 and a current ratio of 1.21. InnovAge has a 1 year low of $3.12 and a 1 year high of $6.69. The company’s 50-day moving average is $4.01 and its two-hundred day moving average is $5.21.

InnovAge (NASDAQ:INNV) last issued its quarterly earnings results on Tuesday, February 4th. The company reported ($0.10) earnings per share (EPS) for the quarter. InnovAge had a negative return on equity of 5.68% and a negative net margin of 2.03%.

Hedge Funds Weigh In On InnovAge

Hedge funds have recently made changes to their positions in the business. SG Americas Securities LLC bought a new position in shares of InnovAge during the 4th quarter worth approximately $43,000. JPMorgan Chase & Co. grew its stake in shares of InnovAge by 191.5% during the 3rd quarter. JPMorgan Chase & Co. now owns 24,687 shares of the company’s stock worth $148,000 after acquiring an additional 16,217 shares in the last quarter. Barclays PLC grew its stake in shares of InnovAge by 289.0% during the 3rd quarter. Barclays PLC now owns 25,614 shares of the company’s stock worth $154,000 after acquiring an additional 19,029 shares in the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of InnovAge by 3.9% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 165,531 shares of the company’s stock worth $993,000 after acquiring an additional 6,153 shares in the last quarter. Finally, State Street Corp grew its stake in shares of InnovAge by 1.2% during the 3rd quarter. State Street Corp now owns 344,905 shares of the company’s stock worth $2,069,000 after acquiring an additional 4,218 shares in the last quarter. 12.26% of the stock is owned by institutional investors.

About InnovAge

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.